This Form 3 is a routine Section 16 filing with no trading activity or material corporate event. Monitor future filings (e.g., Form 4 for any open-market purchases/sales by the insider or the fund) for potential signals. The large disclosed stake (~10.2M shares) suggests significant insider alignment, but no actionable trading signal here.
Price Chart
Executive Summary
Vineeta Agarwala, a managing member of AH EP Bio IV (the general partner of AH Bio Fund IV), filed a Form 3 initial statement of beneficial ownership disclosing 10,232,420 shares of Braveheart Bio, Inc. common stock held indirectly through AH Bio Fund IV. This is a routine initial ownership filing required upon becoming a reporting person under Section 16, with no immediate trading activity or change in company operations.
Key Facts
- Vineeta Agarwala filed a Form 3 initial statement of beneficial ownership for Braveheart Bio, Inc.
- The filing reports 10,232,420 shares of common stock held indirectly through AH Bio Fund IV, L.P.
- AH Bio Fund IV serves as nominee for several affiliated funds, including AH Bio Fund IV-B, L.P., AH 2022 Annual Fund, L.P., and others.
- The reporting person disclaims beneficial ownership of the securities except for her pecuniary interest.
- No open-market transactions or changes in company fundamentals are disclosed in this filing.
Financial Impact
No financial impact — this is a routine initial ownership disclosure with no transaction or change in company value.
Risk Factors
- No material risks identified from this filing alone; it is a routine ownership disclosure.
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0002003663-26-000005 |
| Document: 0002003663-26-000005-index.html | 0002003663-26-000005 |
| Document: 0002003663-26-000005.txt | 0002003663-26-000005 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 10w ago | 3 | $27.66 $26.71 | ▼ −3.43% | ▼ −1.46% | $21.82 (−21.11%) |
Aug 11, 2026 10w ago | Insider Cluster | $26.15 $27.25 | ▲ +4.21% | ▲ +6.10% | $21.82 (−16.56%) |
Aug 11, 2026 10w ago | Insider Cluster | $26.15 $27.25 | ▲ +4.21% | ▲ +6.10% | $21.82 (−16.56%) |
Aug 7, 2026 11w ago | Insider Cluster | $27.53 $29.41 | ▲ +6.83% | ▲ +7.74% | $21.82 (−20.74%) |
Aug 7, 2026 11w ago | Insider Cluster | $27.53 $29.41 | ▲ +6.83% | ▲ +7.74% | $21.82 (−20.74%) |
Aug 5, 2026 11w ago | Press Release | $29.80 $26.27 | ▼ −11.85% | ▼ −12.45% | $21.82 (−26.78%) |
Aug 5, 2026 11w ago | 3 | $29.80 $26.27 | ▼ −11.85% | ▼ −12.45% | $21.82 (−26.78%) |
Aug 5, 2026 11w ago | 3 | $29.80 $26.27 | ▼ −11.85% | ▼ −12.45% | $21.82 (−26.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers